Open Source Pharma Foundation Profile
Key Indicators
- Company Age 8 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 7.96%
(FY 2020)
- Profit -93.23%
(FY 2020)
- Ebitda -4.31%
(FY 2020)
- Net Worth 3350.87%
(FY 2020)
- Total Assets 69.13%
(FY 2020)
About Open Source Pharma Foundation
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.00 and a paid-up capital of Rs 0.00, as per Ministry of Corporate Affairs (MCA) records.
Tanjore Soundararajan and Jaykumar Menon serve as directors at the Company.
- CIN/LLPIN
U74900KA2016NPL086274
- Company No.
086274
- Company Classification
Private Not For Profit Company
- Incorporation Date
17 Feb 2016
- Date of AGM
25 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Open Source Pharma Foundation?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jaykumar Menon  | Managing Director | 17-Feb-2016 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Tanjore Soundararajan  | Director | 17-Feb-2016 | Current |
Financial Performance and Corporate Structure Insights of Open Source Pharma Foundation.
Open Source Pharma Foundation, for the financial year ended 2020, experienced modest growth in revenue, with a 7.96% increase. The company also saw a substantial fall in profitability, with a 93.23% decrease in profit. The company's net worth Soared by an impressive increase of 3350.87%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Open Source Pharma Foundation?
Unlock access to Open Source Pharma Foundation's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Gangagen Biotechnologies Private LimitedActive 24 years 3 monthsTanjore Soundararajan is a mutual person
Ahammune Biosciences Private LimitedActive 8 years 7 monthsTanjore Soundararajan is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Open Source Pharma Foundation?
Unlock and access historical data on people associated with Open Source Pharma Foundation, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Open Source Pharma Foundation, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Open Source Pharma Foundation's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
